RecruitingNCT05593081

Multicenter Study of Fulminant Type 1 Diabetes in China


Sponsor

Second Xiangya Hospital of Central South University

Enrollment

240 participants

Start Date

May 20, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study took FT1D(fulminant type 1 diabetes) as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is collecting data from patients in China with a rare and severe form of type 1 diabetes called fulminant type 1 diabetes, where the pancreas fails very suddenly and completely. Researchers are building a registry to better understand this condition and compare it to healthy individuals. **You may be eligible if...** - You have been diagnosed with fulminant type 1 diabetes, defined by sudden high blood sugar, very low insulin production, and diabetic ketoacidosis shortly after symptoms began - Healthy volunteers are also recruited as a comparison group if they have normal blood sugar on testing **You may NOT be eligible if...** - You were already diagnosed with diabetes before this episode Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICHLA

Distinguish based on clinical features


Locations(10)

Quanzhou First People's Hospital

Quanzhou, Fujian, China

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

Guizhou Provincial People's Hospital

Zunyi, Guangzhou, China

Hainan Provincial People's Hospital

Haikou, Hainan, China

Changsha Central Hospital

Changsha, Hunan, China

Yancheng Third People's Hospital

Yancheng, Jiangs, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Yunnan Provincial People's Hospital

Kunming, Yunnan, China

The Second Xiangya Hospital of Central South University

Changsha, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05593081


Related Trials